Phase II-study Using Ofatumumab and ESHAP Followed by Autologous Trasplant of Hemopoietic Precursors for the Treatment of Classic Hodgkin's Lymphoma on Relapse, Partial Response or Refractory to First Line Treatment.
Latest Information Update: 08 Nov 2021
At a glance
- Drugs Ofatumumab (Primary) ; Cisplatin; Cytarabine; Etoposide; Methylprednisolone
- Indications Hodgkin's disease
- Focus Pharmacogenomic; Therapeutic Use
- 23 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Apr 2015 Status changed from recruiting to active,no longer recruiting as reported by ClinicalTrials.gov.
- 16 Sep 2010 New trial record